Benoit Y.
- Country
- France
- Department
- Medical Oncology
Research Overview
- A Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy
- Evaluation of ASP3082 in Adult Patients with Advanced Solid Tumors
- Phase I Study of OKI-219 Monotherapy and in Combination with Endocrine or HER2-Targeted Therapy in Advanced Solid Tumors and Breast Cancer
Data & Insights
Has run more than one trial at 294 of 549 partner sites.
Specializations
Lung Cancer Therapeutics
This investigator specializes in non-small cell lung cancer (NSCLC) treatment, with particular focus on immunotherapy-based approaches and oligometastatic disease management.
- Advanced NSCLC Treatment Strategies
- Immunotherapy Integration
- Local Ablative Therapies
Their work encompasses innovative therapeutic combinations for various stages of NSCLC.
Targeted Therapy Research
The investigator focuses on molecular-targeted treatments, particularly studying ROS1-rearranged lung cancers and specialized interventions for elderly or frail patients.
- Precision Medicine Applications
- Biomarker-Driven Therapies
- Geriatric Oncology Approaches
Their research addresses specific genetic alterations in lung cancer and personalized treatment strategies.
Small Cell Lung Cancer Innovation
The investigator explores novel therapeutic approaches for limited-disease small cell lung cancer (LD-SCLC), including maintenance immunotherapy following chemoradiotherapy.
- Combined Modality Treatment
- Immunotherapy Maintenance
- Special Population Management
Their work includes developing treatment strategies for vulnerable patient populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.